972
APPENDIX IX
TABLE IX-1 (
con tin u ed
)
Component
Present Reference
Interval
(Examples)
Present
Unit
Conversion
Factor
SI
Reference
Interval
SI Unit
Symbol
Suggested
Significant
Minimum
Digits
Increment
Folate (Ere)
140-960
ng/mL
2.266
550-2200
nmol/L
xxo
10 nmol/L
Follicle stimulating hormone
(FSH) (P)
female
2.0-15.0
mlU/mL
1.00
2-15
IU/L
XX
1 IU/L
peak production
20-50
mlU/mL
1.00
20-50
IU/L
XX
1 IU/L
male
1.0-10.0
mlU/mL
1.00
1-10
IU/L
XX
1 IU/L
Follicle stimulating hormone
(FSH) (U)
follicular phase
2-15
IU/24 h
1.00
2-15
IU/d
XXX
1 IU/d
midcycle
8-40
IU/24 h
1.00
8^10
IU/d
XXX
1
IU/d
luteal phase
2-10
IU/24 h
1.00
2-10
IU/d
XXX
1 IU/d
menopausal women
35-100
IU/24 h
1.00
35-100
IU/d
XXX
1 IU/d
male
2-15
IU/24 h
1.00
2-15
IU/d
XXX
1
IU/d
Fructose (P)
<10
mg/dL
0.05551
<0.6
mmol/L
x.xx
0.1 mmol/L
Galactose (P), children
<20
mg/dL
0.05551
<1.1
mmoI/L
x.xx
0.1 mmol/L
Gases (Ab)
p 0 2
75-105
mmHg (= Torr)
0.1333
10.0-14.0
kPa
xx.x
0.1 kPa
p C 0 2
33^4
mmHg (= Torr)
0.1333
4.4-5.9
kPa
x.x
0.1 kPa
Gamma-glutamyltransferase
0-30
U/L
0.01667
0-0.50
Mkat/L
XXX
0.01 ukat/L
(GGT) (S)
Gastrin (S)
0-180
pg/mL
1
0-180
ng/L
XXO
10 ng/L
Globulins (S) (see immunoglobulins)
Glucagon (S)
50-100
pg/mL
1
50-100
ng/L
xxo
10 ng/L
Glucose (P)—fasting
70-110
mg/dL
0.05551
3.9-6.1
mmol/L
XX.X
0.1 mmol/L
Glucose (Sf)
50-80
mg/dL
0.05551
2.8^1.4
mmol/L
XX.X
0.1 mmol/L
Glutethimide (P)
therapeutic
<10
mg/L
4.603
<46
Mmol/L
XX
1 jjmol/L
toxic
>20
mg/L
4.603
>92
Mmol/L
XX
1
Mmol/L
Glycerol, free (S)
<1.5
mg/dL
0.1086
<0.16
mmol/L
X.XX
0.01 mmol/L
Gold (S)—therapeutic
300-800
Mg/dL
0.05077
15.0-40.0
jumol/L
XX.X
0.1 jtmol/L
Gold (U)
<500
Mg/24 h
0.005077
<2.5
Mmol/d
x.x
0.1 umol/d
Growth hormone (P, S)
male (fasting)
0.0-5.0
ng/mL
1.00
0.0-5.0
Mg/L
xx.x
0.5jttg/L
female (fasting)
0.0-10.0
ng/mL
1.00
0.0-10.0
Mg/L
xx.x
0.5 jt|g/L
Flaptoglobin (S)
50-220
mg/dL
0.01
0.50-2.20
g/L
x.xx
0.01 g/L
Hemoglobin (B)
male
14.0-18.0
g/dL
10.0
140-180
g/L
XXX
1
g/L
female
11.5-15.5
g/dL
10.0
115-155
g/L
XXX
1 g/L
Homogentisate (U) (as
0
mg/24 h
5.947
0
Mmol/d
XX
5 Mmol/d
homogentistic acid)
Homovanillate (U) (as
<8
mg/24 h
5.489
<45
Mmol/d
XX
5 Mmol/d
homovanillic acid)
Beta-hydroxybutyrate (S) (as
<1.0
mg/dL
96.05
<100
Mmol/L
xxo
10MmoI/L
beta-hydroxybutyric acid)
5-Hydroxyindoleacetate (U)
2-8
mg/24 h
5.230
10-40
Mmol/d
XXX
5 Mmol/d
as 5-hydroxyindole
acetic acid; 5 HIAA)
17-Alpha-hydroxyprogesterone
(S,P)
children
0.2-1.4
Mg/L
3.026
0.5—4.5
nmol/L
XX.X
0.5 nmol/L
male
0.5-2.5
M&'L
3.026
1.5-7.5
nmol/L
xx.x
0.5 nmol/L
female
0.3-4.2
Mg/L
3.026
1.0-13.0
nmol/L
xx.x
0.5 nmol/L
female, postmenopausal
0.3-1.7
Mg/L
3.026
1.0-5.0
nmol/L
xx.x
0.5 nmol/L
Hydroxyproline (U)
1 wk-1 y
55-220
mg/24 h/m2
7.626
420-1680
jUmol/(d-m2)
xxo
10Mmol/(d-m2)
1-13 y
25-80
mg/24 h/m2
7.626
190-610
jUmol/(d • m2)
xxo
10 Mmol/(d-m2)
22-65 y
6-22
mg/24 h/m2
7.626
40-170
Mmol/(d-m2)
xxo
10Mmol/(d-m2)
>65 y
5-17
mg/24 h/m2
7.626
40-130
umol/(d-m2)
xxo
10Mmol/(d-m2)
Immunoglobulins (S)
IgG
500-1200
mg/dL
0.01
5.00-12.00
g/L
x x .x x
0.01 g/L
IgA
50-350
mg/dL
0.01
0.50-3.50
g/L
X X .X X
0.01g/L
IgM
30-230
mg/dL
0.01
0.30-2.30
g/L
X X .X X
0.01 g/L
